Abpro Holdings, Inc., a biotechnology company, provides antibody therapeutics for cancer related issues. Its platform DiversImmune addresses the antibody therapeutics. The company's product candidates include ABP-102 for the treatment of breast and gastric cancer; and ABP-110 for the treatment of liver cancer. It also offers ABP-105 for the treatment of gastric cancer and ABP 201 for vascular diseases of the eye and diabetic macular edema. Abpro Holdings, Inc. was incorporated in 2004 and is based in Woburn, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [04/25/2025 10:29 PDT] ABP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/25/2025 16:11 PDT] ABP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/20/2025 08:16 PDT] ABP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/17/2025 11:45 PDT] ABP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/13/2025 10:29 PDT] ABP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/10/2025 12:42 PDT] ABP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/10/2025 07:52 PDT] ABP Expected to Trade Up After Bullish Patterns Develop
• [03/07/2025 07:07 PST] ABP Expected to Trade Up After Bullish Patterns Develop
• [03/03/2025 07:42 PST] ABP Expected to Trade Up After Bullish Patterns Develop